Martin Panigaj

812 total citations
25 papers, 632 citations indexed

About

Martin Panigaj is a scholar working on Molecular Biology, Immunology and Ecology. According to data from OpenAlex, Martin Panigaj has authored 25 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Ecology. Recurrent topics in Martin Panigaj's work include RNA Interference and Gene Delivery (14 papers), Advanced biosensing and bioanalysis techniques (12 papers) and Prion Diseases and Protein Misfolding (5 papers). Martin Panigaj is often cited by papers focused on RNA Interference and Gene Delivery (14 papers), Advanced biosensing and bioanalysis techniques (12 papers) and Prion Diseases and Protein Misfolding (5 papers). Martin Panigaj collaborates with scholars based in United States, Slovakia and Czechia. Martin Panigaj's co-authors include Kirill A. Afonin, Morgan Chandler, M. Brittany Johnson, Mathias Viard, Weina Ke, Jakob Reiser, Wojciech K. Kasprzak, Bruce A. Shapiro, Marina A. Dobrovolskaia and Angélica N. Martins and has published in prestigious journals such as Nucleic Acids Research, Nano Letters and Blood.

In The Last Decade

Martin Panigaj

22 papers receiving 625 citations

Peers

Countries citing papers authored by Martin Panigaj

Since Specialization

Citations

This map shows the geographic impact of Martin Panigaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Panigaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Panigaj more than expected).

Fields of papers citing papers by Martin Panigaj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Panigaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Panigaj. The network helps show where Martin Panigaj may publish in the future.

Co-authorship network of co-authors of Martin Panigaj

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Panigaj. A scholar is included among the top collaborators of Martin Panigaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Panigaj. Martin Panigaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Nucleic Acid Nanoparticles Redefine Traditional Regulatory Terminology: The Blurred Line between Active Pharmaceutical Ingredients and Excipients	PubMed	Martin Panigaj, Hari Bhaskaran et al.	0
2	Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles	ACS Nano	Martin Panigaj, Aleksei Aksimentiev et al.	0
3	Autonomous Nucleic Acid and Protein Nanocomputing Agents Engineered to Operate in Living Cells	ACS Nano	Martin Panigaj, Morgan Chandler et al.	8
4	The Reduction of Traumatic Spinal Cord Secondary Injury by Anti-RhoA siRNA Functionalized Nucleic Acid Nanoparticles (NANPs)	PubMed	Damian Beasock, Morgan Chandler et al.	0
5	Dynamic Nanostructures for Conditional Activation and Deactivation of Biological Pathways	Methods in molecular biology	Martin Panigaj, Kirill A. Afonin et al.	1
6	Therapeutic immunomodulation by rationally designed nucleic acids and nucleic acid nanoparticles	Frontiers in Immunology	Martin Panigaj, Damian Beasock et al.	15
7	Electrochemical Biosensors for Soluble Epidermal Growth Factor Receptor Detection	Electrocatalysis	Martin Panigaj, Pavol Jarčuška et al.	2
8	The Recognition of and Reactions to Nucleic Acid Nanoparticles by Human Immune Cells	Molecules	Marina A. Dobrovolskaia, Martin Panigaj et al.	16
9	Tagging and Capturing of Lentiviral Vectors Using Short RNAs	International Journal of Molecular Sciences	Martin Panigaj, Michael Marino et al.	2
10	Innate immune responses triggered by nucleic acids inspire the design of immunomodulatory nucleic acid nanoparticles (NANPs)	Current Opinion in Biotechnology	Morgan Chandler, M. Brittany Johnson et al.	47
11	Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology	ACS Nano	Martin Panigaj, M. Brittany Johnson et al.	108
12	RNA–DNA fibers and polygons with controlled immunorecognition activate RNAi, FRET and transcriptional regulation of NF-κB in human cells	Nucleic Acids Research	Weina Ke, Enping Hong et al.	63
13	Functionally-interdependent shape-switching nanoparticles with controllable properties	Nucleic Acids Research	Justin R. Halman, Morgan Chandler et al.	73
14	Aptamer guided delivery of nucleic acid-based nanoparticles		Martin Panigaj, Jakob Reiser	4
15	A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins	Gene Therapy	Michael Marino, Martin Panigaj et al.	20
16	Expression of the cellular prion protein affects posttransfusion recovery and survival of red blood cells in mice	Transfusion	Jan Šimák, Martin Panigaj et al.	1
17	Multifunctional RNA Nanoparticles	Nano Letters	Kirill A. Afonin, Mathias Viard et al.	170
18	Development of Monoclonal Antibodies Specific for Glycated Prion Protein	Journal of Toxicology and Environmental Health	Eva Dvořáková, Marek Prouza et al.	3
19	Expression of Prion Protein in Mouse Erythroid Progenitors and Differentiating Murine Erythroleukemia Cells	PLoS ONE	Martin Panigaj, Karel Holada et al.	23
20	Underestimation of the expression of cellular prion protein on human red blood cells	Transfusion	Martin Panigaj, Eva Dvořáková et al.	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact